GPR162 and Alzheimer disease: We began with a logarithmic transformation (Lg) of the labeling ratio of all markers to satisfy a normal distribution and found that the numbers of GABRD+, GPR162+ and pTau217+ EVs were fewer in AD compared to HC in the discovery cohort (Additional file 2: Table S3; Fig. 4a, b, e, f).